ERBB2 c.922G>C ;(p.V308L)

Variant ID: 17-37868201-G-C

NM_004448.2(ERBB2):c.922G>C;(p.V308L)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in BRAF and p.R461* in NF1 Genes-A Case Report with Literature Review.

International Journal Of Molecular Sciences
Grenda, Anna A; Krawczyk, Pawel P; Targowska-Duda, Katarzyna M KM; Kieszko, Robert R; Paśnik, Iwona I; Milanowski, Janusz J
Publication Date: 2023-01-07

Variant appearance in text: ERBB2: V308L
PubMed Link: 36674722
Variant Present in the following documents:
  • Main text
  • ijms-24-01195.pdf
View BVdb publication page



Clinical and Molecular Characteristics of NF1-Mutant Lung Cancer.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Redig, Amanda J AJ; Capelletti, Marzia M; Dahlberg, Suzanne E SE; Sholl, Lynette M LM; Mach, Stacy S; Fontes, Caitlin C; Shi, Yunling Y; Chalasani, Poornima P; Jänne, Pasi A PA
Publication Date: 2016-07-01

Variant appearance in text: ERBB2: V308L
PubMed Link: 26861459
Variant Present in the following documents:
  • Main text
View BVdb publication page